(Q38209972)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804845%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

meta-analysis

0 references

title

ADHD pharmacogenetics across the life cycle: New findings and perspectives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804845%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804845%20AND%20SRC:MED&resulttype=core&format=json

Angélica Salatino-Oliveira

17 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804845%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Christian Kieling

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804845%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Luis Augusto Rohde

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804845%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

4

Verônica Contini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804845%20AND%20SRC:MED&resulttype=core&format=json

Glaucia Chiyoko Akutagava-Martins

17 March 2020

2

object named as

Glaucia Chiyoko Akutagava-Martins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804845%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Estela Maria Bruxel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804845%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

publication date

8 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804845%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

17 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804845%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

165B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804845%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804845%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

263-282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804845%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Modulation of Intracellular Cyclic AMP Levels by Different Human Dopamine D4 Receptor Variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

The long-term effects of prenatal nicotine exposure on neurologic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Effect of osmotic-release oral system methylphenidate on different domains of attention and executive functioning in children with attention-deficit-hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Do phenotypic characteristics, parental psychopathology, family functioning, and environmental stressors have a role in the response to methylphenidate in children with attention-deficit/hyperactivity disorder? A naturalistic study from a developing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a classroom setting in children with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Immunocytochemical localization of the dopamine transporter in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Detecting gene-gene interactions that underlie human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

The neurobiology and genetics of Attention-Deficit/Hyperactivity Disorder (ADHD): What every clinician should know

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Synaptic plasticity and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

A review of the biological bases of ADHD: what have we learned from imaging studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Behavioral and neural consequences of prenatal exposure to nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Pharmacogenomics: the inherited basis for interindividual differences in drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Molecular genetics of attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

An association study of the brain-derived neurotrophic factor Val66Met polymorphism and amphetamine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

A common haplotype at the dopamine transporter gene 5' region is associated with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Structural MRI of pediatric brain development: what have we learned and where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Candidate gene studies of ADHD: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Pharmacogenetic phenotyping and genotyping. Present status and future potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Bupropion hydrochloride in attention deficit disorder with hyperactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Is the inattentive subtype of ADHD different from the combined/hyperactive subtype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Amphetamine, past and present--a pharmacological and clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Allelic Variation of Human Serotonin Transporter Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Genetic variation in brain-derived neurotrophic factor is associated with serotonin transporter but not serotonin-1A receptor availability in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Dopaminergic and noradrenergic gene polymorphisms and response to methylphenidate in korean children with attention-deficit/hyperactivity disorder: is there an interaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

No Association between the Response to Methylphenidate and DRD4 Gene Polymorphism in Korean Attention Deficit Hyperactivity Disorder: A Case Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Lifetime co-morbidity of DSM-IV disorders in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

A current update on ADHD pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Val/Val genotype of brain-derived neurotrophic factor (BDNF) Val⁶⁶Met polymorphism is associated with a better response to OROS-MPH in Korean ADHD children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

ABCB1 c.2677G>T variation is associated with adverse reactions of OROS-methylphenidate in children and adolescents with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Genotype link with extreme antisocial behavior: the contribution of cognitive pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

No support for association between the dopamine transporter (DAT1) gene and ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Dances with black widow spiders: Dysregulation of glutamate signalling enters centre stage in ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Dopamine receptors and the pharmacogenetics of side-effects of stimulant treatment for attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Additional functional variation at the SLC6A4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

The spectrum of behaviors influenced by serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

The dopamine transporter and attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

The neurotrophins and their receptors: structure, function, and neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Pharmacogenetics of methylphenidate response in preschoolers with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Genome-wide association study of blood pressure response to methylphenidate treatment of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Genetic effects on the variation and covariation of attention deficit-hyperactivity disorder (ADHD) and oppositional-defiant disorder/conduct disorder (Odd/CD) symptomatologies across informant and occasion of measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

An integrative theory of attention-deficit/ hyperactivity disorder based on the cognitive and affective neurosciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Measured Gene-by-Environment Interaction in Relation to Attention-Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Association among SNAP-25 gene DdeI and MnlI polymorphisms and hemodynamic changes during methylphenidate use: a functional near-infrared spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Neurotrophin 3 genotype and emotional adverse effects of osmotic-release oral system methylphenidate (OROS-MPH) in children with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Neural hyporesponsiveness and hyperresponsiveness during immediate and delayed reward processing in adult attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Pharmacogenetic approach for a better drug treatment in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: association with the dopamine transporter gene (SLC6A3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Norepinephrine exocytosis stimulated by alpha-latrotoxin requires both external and stored Ca2+ and is mediated by latrophilin, G proteins and phospholipase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

A review of the rationale and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

The human dopamine D4 receptor repeat sequences modulate expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Attention-deficit/hyperactivity disorder and comorbidity in Brazil: comparisons between two referred samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

When parents and teachers disagree about a child's behavior: an opportunity for further evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Reward anticipation and outcomes in adult males with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

An investigation of the neurotrophic factor genes GDNF, NGF, and NT3 in susceptibility to ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Recognition of Impaired Atomoxetine Metabolism Because of Low CYP2D6 Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

The 5-HTTLPR polymorphism of the serotonin transporter gene and short term behavioral response to methylphenidate in children with ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Comprehensive phenotype/genotype analyses of the norepinephrine transporter gene (SLC6A2) in ADHD: relation to maternal smoking during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Brain connectivity in psychiatric imaging genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Synthesis of serotonin by a second tryptophan hydroxylase isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Inheritance and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

From nature versus nurture, via nature and nurture, to gene x environment interaction in mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Association of the dopamine transporter gene (DAT1) with poor methylphenidate response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Association of norepinephrine transporter gene with methylphenidate response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Attention-deficit/hyperactivity disorder (ADHD): feasibility of linkage analysis in a genetic isolate using extended and multigenerational pedigrees

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.32240

21 January 2018

Identifiers

DOI

10.1002/AJMG.B.32240

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24804845%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference